Lucid Diagnostics Company Profile, Contacts & Intelligence

Lucid Diagnostics Overview

Lucid Diagnostics Inc. (Nasdaq: LUCD) is a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM). Lucid is focused on the millions of patients with gastroesophageal disease (GERD), also known as chronic heartburn, who are at risk of developing esophageal precancer and cancer. Lucid’s EsoGuard® Esophageal DNA Test, performed on samples collected in a brief, noninvasive office procedure with its EsoCheck® Esophageal Cell Collection Device, is the first and only commercially available diagnostic test capable of serving as a widespread screening tool to prevent cancer and cancer deaths through early detection of esophageal precancer in at-risk GERD patients. EsoGuard is commercialized in the U.S. as a Laboratory Developed Test (LDT). EsoCheck is commercialized in the U.S. as a 510(k)-cleared esophageal cell collection device.

Headquarters

360 Madison Ave

Website

www.luciddx.com

Industry

Medical Equipment Manufacturing

Founded

2018

Stock Symbol

LUCD

NAICS

Medical Equipment and Supplies Manufacturing, Surgical and Medical Instrument Manufacturing

Phone Number

Available in AeroLeads

Company Email

Available in AeroLeads

Lucid Diagnostics Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Lucid Diagnostics People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Lucid Diagnostics Workforce Composition

Seniority breakdown across 28 visible profiles.

Compare Similar Companies to Lucid Diagnostics

Explore companies in related markets and compare their industry and employee estimates.